Is Eltrombopag/Eltrombopag a hormonal drug? This article will clear up your doubts!

Eltrombopag is a thrombopoietic drug that stimulates the production of platelets in the bone marrow by activating the thrombopoietic factor receptor (TPO receptor). Therefore, it is widely used to treat chronic immune thrombocytopenia (ITP) and some thrombocytopenias caused by myelopoiesis disorders.

Eltrombopag is not a hormonal drug. Hormone drugs generally refer to drugs that work by mimicking or regulating hormone levels in the body, such as steroid drugs. Steroid drugs such as prednisone usually relieve some immune diseases by suppressing immune system responses and reducing inflammation. Eltrombopag's mechanism of action is completely different. It mainly binds to the thrombopoietic factor receptor (TPO receptor) and activates the receptor to promote platelet production in the bone marrow.

Although eltrombopag may have similar effects to steroid drugs in treating certain diseases, its mechanism of action is fundamentally different from hormonal drugs. Eltrombopag is a non-hormonal drug that promotes platelet production. These drugs act directly on the platelet production pathway, rather than by regulating hormone levels in the body. Therefore, Eltrombopag does not have the common side effects of steroid drugs, such as edema, weight gain, immunosuppression, etc.

Although eltrombopag is different from hormonal drugs, eltrombopag may be used in combination with hormonal drugs in some treatment regimens, particularly in the treatment of immune thrombocytopenia (ITP). Typically, hormonal drugs are used to rapidly increase platelet levels during initial treatment, while eltrombopag is used as maintenance therapy to promote platelet production during long-term treatment. Therefore, eltrombopag may be used with steroid medications in some cases, but this does not mean that it is a hormonal medication in its own right.

Reference materials:https://go.drugbank.com/drugs/DB06210